Similar Papers

Paper Title
Journal
Date
Author
An open-label, multicenter study investigating RP3 oncolytic immunotherapy in combination with first- or second-line systemic atezolizumab and bevacizumab therapy in patients with locally advanced unresectable or metastatic hepatocellular carcinoma.
Tanios S Bekaii-Saab ... Wen Wee Ma
Journal of Clinical Oncology | VOL. 41
Tanios S Bekaii-Saab, et. al.Tanios S Bekaii-Saab ... Wen Wee Ma
01 Feb 2023
An open-label, multicenter study investigating RP3 oncolytic immunotherapy in combination with first- or second-line systemic atezolizumab and bevacizumab therapy in patients with locally advanced unresectable or metastatic hepatocellular carcinoma.
Tanios S Bekaii-Saab ... Muneeb Ahmed
Journal of Clinical Oncology | VOL. 41
Tanios S Bekaii-Saab, et. al.Tanios S Bekaii-Saab ... Muneeb Ahmed
01 Jun 2023
An open-label, multicenter study investigating RP3 oncolytic immunotherapy in combination with first- or second-line systemic atezolizumab plus bevacizumab in patients with locally advanced unresectable or metastatic hepatocellular carcinoma.
Kevin Kim ... Aditya Bhansali
Journal of Clinical Oncology | VOL. 42
Kevin Kim, et. al.Kevin Kim ... Aditya Bhansali
20 Jan 2024
A multicenter, open-label study investigating RP2 oncolytic immunotherapy in combination with second-line systemic atezolizumab plus bevacizumab in patients with locally advanced unresectable or metastatic hepatocellular carcinoma (HCC).
Kevin Kim ... Shaheen Kumar
Journal of Clinical Oncology | VOL. 43
Kevin Kim, et. al.Kevin Kim ... Shaheen Kumar
01 Feb 2025
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Expanding the role of CDK4/6 inhibitors in early breast cancer: insights from the NATALEE trial
Marcela Carausu ... Michail Ignatiadis
Annals of Oncology | VOL. 36
Marcela Carausu, et. al.Marcela Carausu ... Michail Ignatiadis
01 Feb 2025
FOxTROT: is anti-EGFR a good dancing partner?
Clara Montagut ... Joana Vidal
Annals of Oncology | VOL. -
Clara Montagut, et. al.Clara Montagut ... Joana Vidal
01 Feb 2025
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Feb 2025
Editorial Board
-
Annals of Oncology | VOL. 36
--
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.